Clorazepate Dipotassium Tablet
NDC Package 51672-4044-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Clorazepate Dipotassium tablets is clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This formulation utilizes a tablet delivery system. Marketed by Taro Pharmaceuticals U.s.a., Inc., this product is identified by NDC 51672-4044 and is authorized under FDA application ANDA075731.

Identification & Billing

NDC Package Code
51672-4044-3
Package Description
1000 TABLET in 1 BOTTLE
Product Code
51672-4044
11-Digit Billing Format
51672404403
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Clorazepate Dipotassium
Non-Proprietary Name
Clorazepate Dipotassium
Substance Name
Clorazepate Dipotassium
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CLORAZEPATE DIPOTASSIUM 15 mg/1
Pharmacologic Class
Usage Information
Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Taro Pharmaceuticals U.s.a., Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA075731
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-27-2000
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51672-4044). Click a package code to view its specific billing and regulatory data.

51672-4044-1
100 TABLET in 1 BOTTLE
51672-4044-2
500 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-4044-3 identifies a specific commercial package of 1000 tablet in 1 bottle of Clorazepate Dipotassium, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. This tablet is formulated for oral use and contains clorazepate dipotassium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Taro Pharmaceuticals U.s.a., Inc. on April 27, 2000. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Clorazepate is used to treat anxiety, acute alcohol withdrawal, and seizures. This medication belongs to a class of drugs called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this Taro Pharmaceuticals U.s.a., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672404403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-4044-3
11-Digit CMS (5-4-2)
51672-4044-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.